162 related articles for article (PubMed ID: 28759222)
1. A Permeability-Limited Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctanoic acid (PFOA) in Male Rats.
Cheng W; Ng CA
Environ Sci Technol; 2017 Sep; 51(17):9930-9939. PubMed ID: 28759222
[TBL] [Abstract][Full Text] [Related]
2. Bayesian Refinement of the Permeability-Limited Physiologically Based Pharmacokinetic Model for Perfluorooctanoic Acid in Male Rats.
Cheng W; Ng CA
Chem Res Toxicol; 2021 Nov; 34(11):2298-2308. PubMed ID: 34705448
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.
Worley RR; Yang X; Fisher J
Toxicol Appl Pharmacol; 2017 Sep; 330():9-21. PubMed ID: 28684146
[TBL] [Abstract][Full Text] [Related]
4. Influence of the uncertainty in the validation of PBPK models: A case-study for PFOS and PFOA.
Fàbrega F; Nadal M; Schuhmacher M; Domingo JL; Kumar V
Regul Toxicol Pharmacol; 2016 Jun; 77():230-9. PubMed ID: 26993749
[TBL] [Abstract][Full Text] [Related]
5. Evaluating parameter availability for physiologically based pharmacokinetic (PBPK) modeling of perfluorooctanoic acid (PFOA) in zebrafish.
Khazaee M; Ng CA
Environ Sci Process Impacts; 2018 Jan; 20(1):105-119. PubMed ID: 29265128
[TBL] [Abstract][Full Text] [Related]
6. Sex, age, and species differences of perfluorooctanoic acid modeled by flow- versus permeability-limited physiologically-based pharmacokinetic models.
Choi GW; Kang DW; Kim JH; Cho SJ; Lee YB; Kwon IH; Cho HY
Toxicology; 2024 Jun; 505():153806. PubMed ID: 38642821
[TBL] [Abstract][Full Text] [Related]
7. PBPK modeling for PFOS and PFOA: validation with human experimental data.
Fàbrega F; Kumar V; Schuhmacher M; Domingo JL; Nadal M
Toxicol Lett; 2014 Oct; 230(2):244-51. PubMed ID: 24440341
[TBL] [Abstract][Full Text] [Related]
8. Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat.
Worley RR; Fisher J
Toxicol Appl Pharmacol; 2015 Dec; 289(3):428-41. PubMed ID: 26522833
[TBL] [Abstract][Full Text] [Related]
9. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.
Kudo N; Kawashima Y
J Toxicol Sci; 2003 May; 28(2):49-57. PubMed ID: 12820537
[TBL] [Abstract][Full Text] [Related]
10. Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK).
Verner MA; Loccisano AE; Morken NH; Yoon M; Wu H; McDougall R; Maisonet M; Marcus M; Kishi R; Miyashita C; Chen MH; Hsieh WS; Andersen ME; Clewell HJ; Longnecker MP
Environ Health Perspect; 2015 Dec; 123(12):1317-24. PubMed ID: 26008903
[TBL] [Abstract][Full Text] [Related]
11. [Researching progresses in environmental pollution behavior, toxic effects and mechanisms of PFOS/PFOA].
Zhou QX; Hu XG
Huan Jing Ke Xue; 2007 Oct; 28(10):2153-62. PubMed ID: 18268971
[TBL] [Abstract][Full Text] [Related]
12. Toxicokinetics of perfluorooctanoate (PFOA) in rainbow trout (Oncorhynchus mykiss).
Consoer DM; Hoffman AD; Fitzsimmons PN; Kosian PA; Nichols JW
Aquat Toxicol; 2014 Nov; 156():65-73. PubMed ID: 25150511
[TBL] [Abstract][Full Text] [Related]
13. In vivo bioavailability and in vitro bioaccessibility of perfluorooctanoic acid (PFOA) in food matrices: correlation analysis and method development.
Li K; Li C; Yu NY; Juhasz AL; Cui XY; Ma LQ
Environ Sci Technol; 2015 Jan; 49(1):150-8. PubMed ID: 25517880
[TBL] [Abstract][Full Text] [Related]
14. Comparison and evaluation of pharmacokinetics of PFOA and PFOS in the adult rat using a physiologically based pharmacokinetic model.
Loccisano AE; Campbell JL; Butenhoff JL; Andersen ME; Clewell HJ
Reprod Toxicol; 2012 Jul; 33(4):452-467. PubMed ID: 21565266
[TBL] [Abstract][Full Text] [Related]
15. Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis.
Cui L; Zhou QF; Liao CY; Fu JJ; Jiang GB
Arch Environ Contam Toxicol; 2009 Feb; 56(2):338-49. PubMed ID: 18661093
[TBL] [Abstract][Full Text] [Related]
16. Parameter grouping and co-estimation in physiologically based kinetic models using genetic algorithms.
Tsiros P; Minadakis V; Li D; Sarimveis H
Toxicol Sci; 2024 Jun; 200(1):31-46. PubMed ID: 38637946
[TBL] [Abstract][Full Text] [Related]
17. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
Chou WC; Lin Z
Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Middle-Out Physiologically Based Toxicokinetic Modeling of Transporter-Dependent Disposition of Perfluorooctanoic Acid in Humans.
Lin J; Chin SY; Tan SPF; Koh HC; Cheong EJY; Chan ECY; Chan JCY
Environ Sci Technol; 2023 May; 57(17):6825-6834. PubMed ID: 37072124
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic modeling of perfluorooctanoic acid during gestation and lactation in the mouse.
Rodriguez CE; Setzer RW; Barton HA
Reprod Toxicol; 2009 Jun; 27(3-4):373-386. PubMed ID: 19429408
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model.
Loccisano AE; Campbell JL; Andersen ME; Clewell HJ
Regul Toxicol Pharmacol; 2011 Feb; 59(1):157-75. PubMed ID: 21168463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
